Showing results (11-20 of 61) with videos related to
Sort By:
Pageof 7
JBMR Plus|September 13, 2023
Hypervitaminosis D Secondary to a <i>CYP24A1</i> Loss-of-Function Mutation: An Unusual Cause of Hypercalcemia in Two SiblingsLucy Collins, Emma Boehm, Catherine Luxford, et al.Best Practice & Research. Clinical Endocrinology & Metabolism|September 13, 2024
Recent progress in molecular classification of phaeochromocytoma and paragangliomaEmma Boehm, Anthony J Gill, Roderick Clifton-Bligh, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 29, 2002
Impact of acute chest pain Tc-99m sestamibi myocardial perfusion imaging on clinical managementJonathan C Knott, Andrew C R Baldey, Leeanne E Grigg, et al.The British Journal of Radiology|March 8, 2021
Aortic root measurement on CT: linear dimensions, aortic root area and comparison with echocardiography. A retrospective cross sectional studyKai'En Leong, Henry Knipe, Simon Binny, et al.Clinical Nuclear Medicine|July 14, 2022
99m Tc-Sestamibi Thyroid Scintigraphy in Amiodarone-Induced Thyrotoxicosis : Functional Imaging-Histopathologic CorrelationRay Wang, Nathan Better, Dinesh Sivaratnam, et al.Clinical Endocrinology|March 24, 2025
Approach to the Management of Gastrointestinal Manifestations in Patients With Phaeochromocytoma and ParagangliomaMonica Majumder, Cherie Chiang, Grace Kong, et al.Clinical Endocrinology|October 9, 2023
Systemic and iatrogenic factors contribute to the development of severe hypernatraemia in vulnerable inpatientsEsha Kathpal, Emma Boehm, Christopher S Nguyen, et al.Nephrology (Carlton, Vic.)|February 20, 2014
Antiphospholipid syndrome in renal transplantationThomas D Barbour, Amy Crosthwaite, Kevin Chow, et al.Nuclear Medicine Communications|January 9, 2015
Quantitative assessment of thyroid-to-background ratio improves the interobserver reliability of technetium-99m sestamibi thyroid scintigraphy for investigation of amiodarone-induced thyrotoxicosisDavid A Pattison, James Westcott, Meir Lichtenstein, et al.Clinical Endocrinology|May 4, 2022
Empiric radioiodine for hyperthyroidism: Outcomes, prescribing patterns, and its place in the modern era of theranosticsEmma Boehm, Yung Hsiang Kao, Jeffrey Lai, et al.Pageof 7